284 results
8-K
EX-99
PFE
Pfizer Inc.
30 Nov 06
Pfizer Presents Robust and Diversified Product Pipeline Across 11 Therapeutic Areas
12:00am
medicines, together with an aggressive business development and licensing strategy, will drive a significant stream of new products for a wide variety … Business Development and Licensing strategy,” said Pfizer Vice-Chairman David Shedlarz. “The first part of our new strategy is a focus on complementing our
425
AZN
Astrazeneca plc
6 May 14
Business combination disclosure
12:00am
strategy is progressing. Before discussing the quarter, I’ll begin with a few words about the proposal we made to AstraZeneca, to combine our two … -forward strategy, regardless of a combination. We see this as further enhancing our strategy, and consistent with creating shareholder value.
Regardless
425
EX-99.8
PFE
Pfizer Inc.
28 Apr 14
Business combination disclosure
12:00am
and speed up medication to patients and would be good for both companies.
The rationale really relates back to our initial strategies. We had a strategy … accelerating shareholder return. That’s been our strategy since the beginning, that has been what’s guided us in the way we’ve managed the business.
So
8-K
EX-99.8
PFE
Pfizer Inc.
28 Apr 14
Possible Offer for Astrazeneca PLC
12:00am
and speed up medication to patients and would be good for both companies.
The rationale really relates back to our initial strategies. We had a strategy … accelerating shareholder return. That’s been our strategy since the beginning, that has been what’s guided us in the way we’ve managed the business.
So
425
rxs 2zv9c7
12 May 14
Business combination disclosure
12:00am
PX14A6G
lnk68 th0302k
6 Apr 20
Letter to shareholders
6:02am
8-K
EX-99.5
kocw9zorrn3v9n5
28 Apr 14
Possible Offer for Astrazeneca PLC
12:00am
425
l6fg2g7ogjon
30 Aug 19
Business combination disclosure
12:37pm
425
perxq5r8guh8sc
29 Apr 14
Business combination disclosure
12:00am
8-K
EX-99
skn8v8 026mp20nk2
23 Apr 12
The Agreement Completes Pfizer’s Previously Announced Review of Strategic Alternatives for its Nutrition Business
12:00am
8-K
EX-99
md52dbzn0k bk6adrk
22 Aug 07
Departure of Directors or Principal Officers
12:00am
425
EX-99.5
l7hwx6nrwoiu4d4ur
28 Apr 14
Business combination disclosure
12:00am
8-K
EX-99
u3cfdkiblh6tq
10 Feb 06
Pfizer Anticipates Sustained Growth of Existing Medicines and Increasing Contribution from Next Generation of Innovative Medicines
12:00am